Skip to search formSkip to main contentSkip to account menu

endobain E

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Ouabain
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Changes in Na+, K+-ATPase Activity and Alpha 3 Subunit Expression in CNS After Administration of Na+, K+-ATPase Inhibitors
The expression of Na+, K+-ATPase α3 subunit and synaptosomal membrane Na+, K+-ATPase activity were analyzed after administration… 
2008
2008
High-affinity Neurotensin Receptor is Involved in Phosphoinositide Turnover Increase by Inhibition of Sodium Pump in Neonatal Rat Brain
Phosphoinositide (PI) metabolism is enhanced in neonatal brain by activation of neurotransmitter receptors and by inhibition of… 
2005
2005
Modulation of Aspartate Release by Ascorbic Acid and Endobain E, an Endogenous Na+, K+-ATPase Inhibitor
The isolation of a soluble brain fraction which behaves as an endogenous ouabain-like substance, termed endobain E, has been… 
2005
2005
Endobain E, a brain endogenous factor, is present and modulates NMDA receptor in ischemic conditions.
2004
2004
Allosteric modulation of [3H]dizocilpine binding to N-methyl-d-aspartate receptor by an endogenous Na+, K+-ATPase inhibitor: dependence on receptor activation
2002
2002
Metabotropic glutamate receptor involvement in phosphoinositide hydrolysis stimulation by an endogenous Na(+), K(+)-ATPase inhibitor and ouabain in neonatal rat brain.
2001
2001
[3H]Dizocilpine binding to N-methyl-d-aspartate (NMDA) receptor is modulated by an endogenous Na+, K+-ATPase inhibitor. Comparison with ouabain
1998
1998
Na+,K+-ATPase interaction with a brain endogenous inhibitor (endobain E)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)